BioCardia (BCDA) Operating Expenses (2010 - 2026)

BioCardia (BCDA) has reported Operating Expenses for 15 consecutive years, with $1.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Expenses fell 20.87% year-over-year to $1.6 million in Q2 2026; TTM through Jun 2026 was $7.4 million, a 16.11% decrease from a year earlier, with the FY2024 full-year figure at $8.1 million, down 33.51% from the prior year.
• Operating Expenses was $1.6 million for Q2 2026 at BioCardia, down from $2.3 million in the prior quarter.
• Over five years, Operating Expenses peaked at $3.6 million in Q1 2023 and troughed at $1.5 million in Q3 2025.
• A 5-year average of $2.6 million and a median of $2.3 million in 2024 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses slumped 52.73% in 2024 and climbed 24.15% in 2025, its largest moves.
• Over 5 years, Operating Expenses stood at $3.1 million in 2022, then tumbled by 32.87% to $2.1 million in 2023, then gained by 10.68% to $2.3 million in 2024, then sank by 35.89% to $1.5 million in 2025, then rose by 9.07% to $1.6 million in 2026.
• The last three Operating Expenses figures came in at $1.6 million (Q2 2026), $2.3 million (Q1 2026), and $1.5 million (Q3 2025), per Business Quant data.